<VariationArchive RecordType="classified" VariationID="9970" VariationName="NM_002024.6(FMR1):c.373del (p.Thr125fs)" VariationType="Deletion" Accession="VCV000009970" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-08-06" DateCreated="2017-10-12" MostRecentSubmission="2017-10-12">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="25009" VariationID="9970">
      <GeneList>
        <Gene Symbol="FMR1" FullName="fragile X messenger ribonucleoprotein 1" GeneID="2332" HGNC_ID="HGNC:3775" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xq27.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="147911919" stop="147951125" display_start="147911919" display_stop="147951125" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="146993468" stop="147032646" display_start="146993468" display_stop="147032646" Strand="+" />
          </Location>
          <OMIM>309550</OMIM>
          <Haploinsufficiency last_evaluated="2020-12-16" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FMR1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-12-16" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FMR1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_002024.6(FMR1):c.373del (p.Thr125fs)</Name>
      <CanonicalSPDI>NC_000023.11:147928760:A:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xq27.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="147928761" stop="147928761" display_start="147928761" display_stop="147928761" variantLength="1" positionVCF="147928760" referenceAlleleVCF="TA" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="147010279" stop="147010279" display_start="147010279" display_stop="147010279" variantLength="1" positionVCF="147010278" referenceAlleleVCF="TA" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>T125fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.147928761del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.147928761del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.147010279del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.147010279del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007529.2" sequenceAccession="NG_007529" sequenceVersion="2" change="g.21771del">
            <Expression>NG_007529.2:g.21771del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001185075.2" sequenceAccession="NM_001185075" sequenceVersion="2" change="c.373del">
            <Expression>NM_001185075.2:c.373del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001172004.1" sequenceAccession="NP_001172004" sequenceVersion="1" change="p.Thr125fs">
            <Expression>NP_001172004.1:p.Thr125fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001185076.2" sequenceAccession="NM_001185076" sequenceVersion="2" change="c.373del">
            <Expression>NM_001185076.2:c.373del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001172005.1" sequenceAccession="NP_001172005" sequenceVersion="1" change="p.Thr125fs">
            <Expression>NP_001172005.1:p.Thr125fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001185081.2" sequenceAccession="NM_001185081" sequenceVersion="2" change="c.373del">
            <Expression>NM_001185081.2:c.373del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001172010.1" sequenceAccession="NP_001172010" sequenceVersion="1" change="p.Thr125fs">
            <Expression>NP_001172010.1:p.Thr125fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001185082.2" sequenceAccession="NM_001185082" sequenceVersion="2" change="c.373del">
            <Expression>NM_001185082.2:c.373del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001172011.1" sequenceAccession="NP_001172011" sequenceVersion="1" change="p.Thr125fs">
            <Expression>NP_001172011.1:p.Thr125fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_002024.6" sequenceAccession="NM_002024" sequenceVersion="6" change="c.373del" MANESelect="true">
            <Expression>NM_002024.6:c.373del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_002015.1" sequenceAccession="NP_002015" sequenceVersion="1" change="p.Thr125fs">
            <Expression>NP_002015.1:p.Thr125fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_033699.2" sequenceAccession="NR_033699" sequenceVersion="2" change="n.634del">
            <Expression>NR_033699.2:n.634del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_033700.2" sequenceAccession="NR_033700" sequenceVersion="2" change="n.634del">
            <Expression>NR_033700.2:n.634del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_762" sequenceAccession="LRG_762">
            <Expression>LRG_762:g.21771del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="309550.0002" DB="OMIM" />
        <XRef Type="rs" ID="1569545562" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_002024.6(FMR1):c.373del (p.Thr125fs) AND Fragile X syndrome" Accession="RCV000010649" Version="6">
        <ClassifiedConditionList TraitSetID="2820">
          <ClassifiedCondition DB="MedGen" ID="C0016667">Fragile X syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1995-08-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="1995-08-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2017-10-12" MostRecentSubmission="2017-10-12">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">7670500</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="2820" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1302" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">MENTAL RETARDATION, X-LINKED, ASSOCIATED WITH marXq28</ElementValue>
                <XRef Type="MIM" ID="300624" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Fragile X syndrome</ElementValue>
                <XRef ID="Fragile+X+Syndrome/2906" DB="Genetic Alliance" />
                <XRef ID="MONDO:0010383" DB="MONDO" />
                <XRef ID="613003" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Marker X syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Martin-Bell syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Fra(X) syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">X-linked mental retardation and macroorchidism</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Fragile X syndrome, type A</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000264966" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000552393" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000553203" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000561923" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000576178" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592287" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000596783" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569189" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000571198" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556541" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000560955" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000568029" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569426" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569960" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592286" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592289" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592335" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558914" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000568236" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000568277" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000570010" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592290" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592423" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">FMR1 disorders include fragile X syndrome (FXS), fragile X-associated tremor/ataxia syndrome (FXTAS), and fragile X-associated primary ovarian insufficiency (FXPOI). Fragile X syndrome occurs in individuals with an FMR1 full mutation or other loss-of-function variant and is nearly always characterized in affected males by developmental delay and intellectual disability along with a variety of behavioral issues. Autism spectrum disorder is present in 50%-70% of individuals with FXS. Affected males may have characteristic craniofacial features (which become more obvious with age) and medical problems including hypotonia, gastroesophageal reflux, strabismus, seizures, sleep disorders, joint laxity, pes planus, scoliosis, and recurrent otitis media. Adults may have mitral valve prolapse or aortic root dilatation. The physical and behavioral features seen in males with FXS have been reported in females heterozygous for the FMR1 full mutation, but with lower frequency and milder involvement. FXTAS occurs in individuals who have an FMR1 premutation and is characterized by late-onset, progressive cerebellar ataxia and intention tremor followed by cognitive impairment. Psychiatric disorders are common. Age of onset is typically between 60 and 65 years and is more common among males who are hemizygous for the premutation (40%) than among females who are heterozygous for the premutation (16%-20%). FXPOI, defined as hypergonadotropic hypogonadism before age 40 years, has been observed in 20% of women who carry a premutation allele compared to 1% in the general population.</Attribute>
                <XRef ID="NBK1384" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">FMR1-Related Disorders</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6464" />
                <XRef ID="6464" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301558</ID>
                <ID Source="BookShelf">NBK1384</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2001">
                <ID Source="pmc">3110344</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2008">
                <ID Source="pmc">3111012</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2005">
                <ID Source="pmc">3110946</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2008">
                <ID Source="pmc">3111547</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
                <ID Source="PubMed">21540884</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2012">
                <ID Source="PubMed">22797890</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23519317</ID>
              </Citation>
              <Citation Type="general" Abbrev="EMQN, 2015">
                <ID Source="PubMed">25227148</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23765048</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2021">
                <ID Source="PubMed">33795824</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2012">
                <URL>https://www.acmg.net/PDFLibrary/Fragile-X-ACT.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics Genetic Testing ACT Sheet, Fragile X [FraX] Syndrome, 2012</CitationText>
              </Citation>
              <XRef ID="449291" DB="Orphanet" />
              <XRef ID="908" DB="Orphanet" />
              <XRef ID="C0016667" DB="MedGen" />
              <XRef ID="MONDO:0010383" DB="MONDO" />
              <XRef Type="MIM" ID="300624" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="30875" SubmissionDate="2017-10-09" DateLastUpdated="2017-10-12" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="309550.0002_FRAGILE X SYNDROME" title="FMR1, 1-BP DEL, 373A_FRAGILE X SYNDROME" />
        <ClinVarAccession Accession="SCV000030875" DateUpdated="2017-10-12" DateCreated="2013-04-04" Type="SCV" Version="4" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1995-08-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a young male patient with fragile X syndrome (FXS; 300624), Lugenbeel et al. (1995) identified a de novo 1-bp deletion (373delA) in exon 5 of the FMR1 gene, resulting in a frameshift and premature termination of the protein at residue 159. Western blot analysis detected no Fmr1 protein. The finding provided strong evidence that absence of FMRP leads directly to fragile X syndrome and suggested that downregulation of other nearby genes is not likely to contribute to the phenotype.</Attribute>
              <Citation>
                <ID Source="PubMed">7670500</ID>
              </Citation>
              <XRef DB="OMIM" ID="300624" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FMR1" />
          </GeneList>
          <Name>FMR1, 1-BP DEL, 373A</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 373A</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="309550.0002" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">FRAGILE X SYNDROME</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="30875" TraitType="Disease" MappingType="Name" MappingValue="FRAGILE X SYNDROME" MappingRef="Preferred">
        <MedGen CUI="C0016667" Name="Fragile X syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

